Local view for "http://purl.org/linkedpolitics/eu/plenary/2011-04-07-Speech-4-183-500"
| Predicate | Value (sorted: default) |
|---|---|
| rdf:type | |
| dcterms:Date | |
| dcterms:Is Part Of | |
| dcterms:Language | |
| lpv:document identification number |
"en.20110407.18.4-183-500"2
|
| lpv:hasSubsequent | |
| lpv:speaker | |
| lpv:spokenAs | |
| lpv:translated text |
"I voted in favour of this report, because bluetongue is a disease affecting ruminants (such as cattle, sheep and goats). Since the early 2000s, several epidemic waves of disease have occurred in many Member States, including central and northern Europe, causing significant losses in terms of morbidity, mortality and disruption of trade in live animals. Hitherto, the provisions for the control and eradication of bluetongue have been based on experience of the use of live attenuated vaccines that were the only vaccines available. Those vaccines may lead to undesired circulation of the vaccine virus in unvaccinated animals. In the last few years, however, new inactivated vaccines have become available. Unlike the ‘live attenuated vaccines’, these inactivated vaccines do not pose the risk of undesired vaccine virus circulation and can therefore be successfully used outside areas subject to animal movement restrictions. This proposal would relax some restrictions, which have become unnecessary in light of the recent developments in vaccine production. The new rules would help Member States to make more effective use of vaccination to control bluetongue and reduce the burden on the agricultural sector posed by this disease."@en1
|
Named graphs describing this resource:
The resource appears as object in 2 triples